A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
Conditions
- Epithelial Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Cancer
- Ovarian Cancer
Interventions
- DRUG: Mirvetuximab soravtansine
- DRUG: Paclitaxel
- DRUG: Pegylated liposomal doxorubicin
- DRUG: Topotecan
Sponsor
ImmunoGen, Inc.
Collaborators